Below are the most recent publications written about "Positron-Emission Tomography" by people in Profiles.
-
Cousins KAQ, Korecka M, Wan Y, Vulaj A, Brown C, Tropea TF, Lee EB, Tosun D, Landau SM, Okonkwo OC, Mindt MR, Weiner MW, Irwin DJ, Wolk DA, Shaw LM. Comparison of plasma p-tau217/A?42, p-tau217, and A?42/A?40 biomarkers by race to detect Alzheimer's disease. Alzheimers Dement. 2025 Aug; 21(8):e70469.
-
Azimi MS, Felfelian V, Zeraatkar N, Dadgar H, Arabi H, Zaidi H. Deep supervised transformer-based noise-aware network for low-dose PET denoising across varying count levels. Comput Biol Med. 2025 Sep; 196(Pt A):110733.
-
Mil?-Alom? M, Tosun D, Schindler SE, Hausle I, Petersen KK, Li Y, Dage JL, Du-Cuny L, Saad ZS, Saef B, Triana-Baltzer G, Raunig DL, Coomaraswamy J, Baratta M, Meyers EA, Mordashova Y, Rubel CE, Ferber K, Kolb H, Ashton NJ, Zetterberg H, Rosenbaugh EG, Sabandal M, Shaw LM, Bannon AW, Potter WZ. Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks. Ann Neurol. 2025 Sep; 98(3):508-523.
-
Duong MT, Das SR, Khandelwal P, Lyu X, Xie L, McGrew E, Dehghani N, McMillan CT, Lee EB, Shaw LM, Yushkevich PA, Wolk DA, Nasrallah IM. Hypometabolic mismatch with atrophy and tau pathology in mixed Alzheimer's and Lewy body disease. Brain. 2025 May 13; 148(5):1577-1587.
-
Ding H, Lyu C, Karjadi C, Sunderaraman P, Young CB, Mormino EC, Low S, Devine S, Gifford K, Au R, Lin H. Association of the digital clock drawing test with amyloid and tau PET biomarkers in low age risk adults. Sci Rep. 2025 Apr 01; 15(1):11104.
-
Leuzy A, Bollack A, Pellegrino D, Teunissen CE, La Joie R, Rabinovici GD, Franzmeier N, Johnson K, Barkhof F, Shaw LM, Arkhipenko A, Schindler SE, Honig LS, Moscoso Rial A, Sch?ll M, Zetterberg H, Blennow K, Hansson O, Farrar G. Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease. Alzheimers Dement. 2025 Mar; 21(3):e14528.
-
Kuhn E, Klinger HM, Amariglio RE, Wagner M, Jessen F, D?zel E, Heneka MT, Ch?telat G, Rentz DM, Sperling RA, Ebenau JL, Butterbrod E, Van Der Flier WM, Sikkes SAM, Teunnissen CE, Van Harten AC, Van De Giessen EM, Rami L, Tort A, S?nchez Benavides G, Gifford KA, Van Hulle C, Buckley RF. SCD-plus features and AD biomarkers in cognitively unimpaired samples: A meta-analytic approach for nine cohort studies. Alzheimers Dement. 2025 May; 21(5):e14307.
-
Baran J, Krzemien W, Parzych S, Raczynski L, Bala M, Coussat A, Chug N, Czerwinski E, Curceanu CO, Dadgar M, Dulski K, Eliyan K, Gajewski J, Gajos A, Hiesmayr BC, Kacprzak K, Kaplon L, Klimaszewski K, Korcyl G, Kozik T, Kumar D, Niedzwiecki S, Panek D, Perez Del Rio E, Rucinski A, Sharma S, Shopa RY, Skurzok M, Stepien E, Tayefiardebili F, Tayefiardebili K, Wislicki W, Moskal P. Realistic total-body J-PET geometry optimization: Monte Carlo study. Med Phys. 2025 May; 52(5):2961-2975.
-
Weiner MW, Kanoria S, Miller MJ, Aisen PS, Beckett LA, Conti C, Diaz A, Flenniken D, Green RC, Harvey DJ, Jack CR, Jagust W, Lee EB, Morris JC, Nho K, Nosheny R, Okonkwo OC, Perrin RJ, Petersen RC, Rivera-Mindt M, Saykin AJ, Shaw LM, Toga AW, Tosun D, Veitch DP. Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials. Alzheimers Dement. 2025 Jan; 21(1):e14321.
-
Beatty CW, Ahrens SM, Arredondo KH, Bagic AI, Bai S, Chapman KE, Ciliberto MA, Clarke DF, Eisner M, Fountain NB, Gavvala JR, Perry MS, Rossi KC, Wong-Kisiel LC, Herman ST, Ostendorf AP. Associations Between Testing and Treatment Pathways in a Case of Pediatric Nonlesional Epilepsy: A Census Survey of NAEC Center Directors. J Child Neurol. 2025 Mar; 40(3):162-167.